Diffusion tensor imaging of basal ganglia and thalamus in amyotrophic lateral sclerosis

Journal of Neuroimaging

Volumn 23, Issue 3, 2013, Pages 368-374

  Sharma, Khema R ^a   Sheriff, Sulaiman ^a   Maudsley, Andrew ^a   Govind, Varan ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Amyotrophic lateral sclerosis; Basal ganglia; DTI; Extra motor; Thalamus

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BASAL GANGLION; BODY MOVEMENT; BRAIN NERVE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; EXTRAPYRAMIDAL SYSTEM; FEMALE; FINGER; FOOT; GLOBUS PALLIDUS; HUMAN; LIP; MALE; MOTOR DYSFUNCTION; NERVE CELL NECROSIS; NUCLEAR MAGNETIC RESONANCE SCANNER; PYRAMIDAL TRACT; THALAMUS; TONGUE; COMPUTER ASSISTED DIAGNOSIS; MIDDLE AGED; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; BASAL GANGLIA; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THALAMUS;

EID: 84879842600     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2011.00679.x     Document Type: Article

References (39)

1. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001;344:1688-1700.
2. Brownell B, Oppenheimer DR, Hughes JT. The central nervous system in motor neuron disease. J. Neurol Neurosurg Psychiatry 1970;33:338-357.
3. Kato S, Oda M, Hayashi H. Neuropathology in amyotrophic lateral sclerosis patients on respirators: uniformity and diversity in 13 cases. Neuropathol 1993;13:229-236.
4. Piao YS, Wakabayashi K, Kakita A, et al. Neuropathology with clinical correlations of sporadic amyotrophic lateral sclerosis: 102 autopsy cases examined between 1962 and 2000. Brain Pathol 2003;12:10-22.
5. Geser F, Brandmeir N, Kwong L, et al. Evidence for multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol 2008;65:636-641.
6. Ringholz G, Appel S, Bradshaw M, et al. Prevalence and pattern of cognitive impairment in sporadic amyotrophic lateral sclerosis. Neurology 2005;65:586-590.
7. Thivard L, Pradat P, Lehericy S, et al. Diffusion tension imaging and voxel based morphometry study in amyotrophic lateral sclerosis: relationships with motor disability. J Neurol Neurosurg Psychiatry 2007;78:889-892.
8. Li S, Chen Q, Yu B, et al. Structural and functional changes mapped in the brain of amyotrophic lateral sclerosis patients with/without dysphagia: pilot study. Amyotroph Lateral Scler 2009;10:280-287.
9. Sach M, Winkler G, Glauche V, et al. Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis. Brain 2004;127:340-350.
10. 11C]®-PK11195 positron emission tomography study. Neurobiol Dis 2004;15:601-609.
11. Agosta F, Gorono-Tempini M, Pagani E, et al. Longitudinal assessment of grey matter contraction in amyotrophic lateral sclerosis: a tensor based morphometry study. Amyotroph Lateral Scler 2009;10:168-174.
12. Sharma KR, Govind V, Sheriff S, et al. Proton MRS of thalamus and basal ganglia in amyotrophic lateral sclerosis. NMR Biomed 2011 (March 15, 2011; Epub: DOI:10.1002/nbm.1687).
13. Brooks BR, Miller RG, Swash M, et al. World Federation of Neurology Research Group on motor neuron disease. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-299.
14. Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 1999;169:13-21.
15. Agostino R, Berardelli A, Curra A, et al. Clinical impairment of sequential finger movements in Parkinson's disease. Mov Disord 1998;13:418-421.
16. Norlinah IM, Bhatia KP, Ostergaard K, et al. Primary lateral sclerosis mimicking atypical parkinsonism. Mov Dosord 2007;22:2057-2062.
17. Goetz CG, Tilley BC, Shaftman SR, et al. Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008;23:2129-2170.
18. Mitsumoto H, Ulung A, Pullman S, et al. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology 2007;68:1402-1410.
19. Kasarskis EJ, Scarlata D, Hill R, et al. BDNF Phase III and CNTF treatment study (ACTS) groups. A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials. J Neurol Sci 1999; 169:118-125.
20. Nasreddin Z, Phillips N, Bedirian V, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695-699.
21. DeLong MR, Wichmann T. Circuits and circuit disorders of the basal ganglia. Arch Neurol 2007;64:20-24.
22. Middleton FA, Strick PL. Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res Rev 2000;31:236-250.
23. Takahashi H, Snow BJ Bhatt MH, et al. Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning. Lancet 1993;342:1016-1018.
24. Przedborsk S, Dhawan V, Donaldson DM, et al. Nigrostriatal dopaminergic function in familial amyotrophic lateral sclerosis patients with and without copper/zinc superoxide dismutase mutations. Neurology 1996;47:1546-1551.
25. Borasio GD, Linke R, Schwarz J, et al. Dopaminergic deficit in amyotrophic lateral sclerosis assessed with [I-123] IPT single photon emission computed tomography. J Neurol Neurosurg Psychiatry 1998;65:263-265.
26. Vogels OJ, Veltman J, Oyen WJ, et al. Decreased striatal dopamine D2 receptor binding in amyotrophic lateral sclerosis (ALS) and multisystem atrophy (MSA): D2 receptor down-regulation versus stiatal cell degeneration. J Neurol Sci 2000;180:62-65.
27. Kostic V, Gurney ME, Deng H, et al. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis. Ann Neurol 1997;41:497-504.
28. Rathke-Hartlieb S, Schmidt VC, Jokusch H, et al. Spatiotemporal progression of neurodegeneration and glia activation in the wobbler neuropathy of the mouse. NeuroReport 1999;10:3411-3416.
29. Kiernan JA, Hudson AJ. Frontal lobe atrophy in motor neuron diseases. Brain 1994; 117: 747-757.
30. Cote L, Ciutcher M. Motor functions of the basal ganglia and diseases of transmitter metabolism. In: Kandle ER, Schwartz JH, eds. Principles of Neural Science, 2nd ed. editors:. New York: Elsevier Science Publishing, 1985: 523-535.
31. Davidoff RA. The pyramidal tract. Neurology 1990;40:332-340.
32. Ince PG, Evans J, Knopp M, et al. Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology 2003;60:1252-1258.
33. Kaufmann P, Pullman S, Shungu D, et al. Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology 2004;62:1753-1757.
34. Kent-Braun J, Walker CH, Weiner M, et al. Functional significance of upper and lower motor neuron impairment in amyotrophic lateral sclerosis. Muscle Nerve 1998; 21:762-768.
35. Toosy AT, Werring DJ, Orrell RW, et al. Diffusion tensor imaging detects corticospinal tract involvement at multiple levels in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2003;74:1250-1257.
36. Karlsborg M, Rosenbaum S, Wiegell M, et al. Corticospinal tract degeneration and possible pathogenesis in ALS evaluated by MR diffusion tensor imaging. Amyotroph Lateral Scler 2004;5:136-140.
37. Hong Y, Lee K, Sung J, et al. Diffusion tensor MRI as a diagnostic tool of upper motor neuron involvement in amyotrophic lateral sclerosis. J Neurol Sci 2004;227:73-78.
38. Graham JM, Papadakins N, Evans J, et al. Diffusion tensor imaging for the assessment of the upper motor neuron integrity in ALS. Neurology 2004;63:2111-2119.
39. Pierpaoli C, Barnett A, Pajevic S, et al. Water diffusion changes in Wallerian degeneration and their dependence on white matter architecture. NeuroImage 2001;13:1174-1185.